[ Price : $8.95]
FDA approves Genentechs Gazyva (obinutuzumab) for treating adult patients with active lupus nephritis who are receiving standard t...[ Price : $8.95]
FDA releases hiring data showing steep declines in staffing at CDER and CBER.[ Price : $8.95]
FDA warns St. Louis, MO-based BRS Analytical Services about CGMP violations in its production of finished drugs.[ Price : $8.95]
GSK and Spero Therapeutics report positive Phase 3 results for tebipenem HBr, an investigational oral antibiotic for complicated u...[ Price : $8.95]
FDA says it is strengthening labeling for tranexamic acid injection products to clarify that it is only to be administered intrave...[ Price : $8.95]
FDA contracts with the Institute for Safe Medication Practices for services to strengthen its ability to identify and reduce the r...[ Price : $8.95]
FDA hosts a one-day public workshop 10/23 to explore new approaches for approving patch test allergens used in diagnosing allergic...[ Price : $8.95]
FDA accepts for review a Replimune BLA resubmission for RP1 (vusolimogene oderparepvec) in combination with nivolumab for treating...